Cossar, R. D., Stewart, A. C., Wilkinson, A. L., Dietze, P., Ogloff, J. R. P., Aitken, C., Butler, T., Kinner, S. A., Curtis, M., Walker, S., Kirwan, A., & Stoové, M. (2022). Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study [10.1016/j.drugpo.2021.103532]. International Journal of Drug Policy, 101. https://doi.org/10.1016/j.drugpo.2021.103532

Cranney, L., McGill, B., Clare, P. J., & Bauman, A. (2022). Trends in risk factors and management strategies used by people with type 2 diabetes in New South Wales, Australia [10.1016/j.ypmed.2022.107004]. Preventive Medicine, 157. https://doi.org/10.1016/j.ypmed.2022.107004

Cunningham, E. B., Wheeler, A., Hajarizadeh, B., French, C. E., Roche, R., Marshall, A. D., Fontaine, G., Conway, A., Valencia, B. M., Bajis, S., Presseau, J., Ward, J. W., Degenhardt, L., Dore, G. J., Hickman, M., Vickerman, P., & Grebely, J. (2022). Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis [10.1016/S2468-1253(21)00471-4]. The Lancet Gastroenterology and Hepatology, 7(5), 426-445. https://doi.org/10.1016/S2468-1253(21)00471-4

Curtis, M., Winter, R. J., Dietze, P., Wilkinson, A. L., Cossar, R. D., Stewart, A. C., Agius, P. A., Butler, T., Aitken, C., Kirwan, A., Walker, S., & Stoové, M. (2022). High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment [10.1111/add.15971]. Addiction, 117(11), 2887-2898. https://doi.org/10.1111/add.15971

Daly, C., Maravilla, J., Thomas, N., Salom, C., & Juckel, J. (2022). Queensland Drug Trends 2021: Key Findings from the Illicit Drug Reporting System (IDRS) Interviews [10.26190/ftn4-sd95].

Darke, S., Chrzanowska, A., Campbell, G., Zahra, E., & Lappin, J. (2022). Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018 [10.5694/mja2.51306]. MEDICAL JOURNAL OF AUSTRALIA, 216(4), 194-198. https://doi.org/10.5694/mja2.51306

Darke, S., Duflou, J., Peacock, A., Farrell, M., & Lappin, J. (2022). Characteristics of fatal tapentadol-related toxicity in Australia [10.1111/dar.13462]. Drug and Alcohol Review, 41(5), 1071-1077. https://doi.org/10.1111/dar.13462

Darke, S., Peacock, A., Duflou, J., Farrell, M., & Lappin, J. (2022). Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia [10.1016/j.drugalcdep.2022.109292]. Drug and Alcohol Dependence, 232. https://doi.org/10.1016/j.drugalcdep.2022.109292

Day, C. A., Salmon, A., Jauncey, M., Bartlett, M., & Roxburgh, A. (2022). Twenty-one years at the Uniting Medically Supervised Injecting Centre, Sydney: addressing the remaining questions [10.5694/mja2.51716]. MEDICAL JOURNAL OF AUSTRALIA, 217(8), 385-387. https://doi.org/10.5694/mja2.51716

Deans, E., Ravulo, J., Conroy, E., & Abdo, J. (2022). A qualitative study exploring young offenders’ perspectives on alcohol and other drug health promotion [10.1186/s12889-022-12953-z]. BMC Public Health, 22(1). https://doi.org/10.1186/s12889-022-12953-z

Degan, T. J., Kelly, P. J., Robinson, L. D., Deane, F. P., & Baker, A. L. (2022). Health literacy and healthcare service utilisation in the 12-months prior to entry into residential alcohol and other drug treatment [10.1016/j.addbeh.2021.107111]. Addictive Behaviors, 124. https://doi.org/10.1016/j.addbeh.2021.107111

Degenhardt, L., Bharat, C., Glantz, M. D., Bromet, E. J., Alonso, J., Alonso, J., Alonso, J., Bruffaerts, R., Bunting, B., de Girolamo, G., de Jonge, P., de Jonge, P., Florescu, S., Gureje, O., Haro, J. M., Harris, M. G., Harris, M. G., Hinkov, H., Karam, E. G., . . . Wojtyniak, B. (2022). The associations between traumatic experiences and subsequent onset of a substance use disorder: Findings from the World Health Organization World Mental Health surveys [10.1016/j.drugalcdep.2022.109574]. Drug and Alcohol Dependence, 240. https://doi.org/10.1016/j.drugalcdep.2022.109574